China Healthwise Holdings Limited (HKG:0348)
Hong Kong · Delayed Price · Currency is HKD 0.0700
+0.0010 (1.45%)
Sep 11, 2026, 3:29 PM HKT
China Healthwise Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 84.97 | 99.56 | 113.58 | 146.32 | 142.06 | 170.08 | |
Revenue Growth | -18.07% | -12.34% | -22.38% | 3.00% | -16.48% | 23.38% |
Cost of Revenue | 63.27 | 62.94 | 78.58 | 193.49 | 113.57 | 181.69 |
Gross Profit | 21.7 | 36.62 | 35 | -47.18 | 28.49 | -11.61 |
Selling, General & Admin | 49.71 | 49.86 | 55.45 | 65.4 | 66.87 | 64.17 |
Operating Expenses | 49.1 | 49.25 | 55.45 | 65.4 | 66.87 | 64.17 |
Operating Income | -27.4 | -12.63 | -20.45 | -112.58 | -38.39 | -75.79 |
Interest Expense | -13.66 | -13.83 | -8.3 | -8.99 | -7.3 | -6.41 |
Interest & Investment Income | 0 | - | - | - | - | - |
Other Non Operating Income (Expenses) | -1.12 | -0.12 | 0.01 | 0.18 | 0.7 | 0 |
EBT Excluding Unusual Items | -42.17 | -26.57 | -28.74 | -121.39 | -44.98 | -82.19 |
Gain (Loss) on Sale of Investments | -17.1 | - | - | -10.34 | -15.33 | -15.3 |
Gain (Loss) on Sale of Assets | 24.61 | 24.61 | -4.19 | - | - | - |
Asset Writedown | -0.5 | -1.33 | -0.8 | -0.32 | -0.62 | -3.24 |
Other Unusual Items | - | - | -6.3 | - | 4.53 | 0.15 |
Pretax Income | -35.16 | -3.29 | -40.03 | -132.06 | -56.4 | -100.58 |
Income Tax Expense | -2.04 | -0.69 | 0.25 | 2.5 | -2.13 | 2.47 |
Earnings From Continuing Operations | -33.12 | -2.61 | -40.28 | -134.56 | -54.27 | -103.05 |
Net Income to Company | -33.12 | -2.61 | -40.28 | -134.56 | -54.27 | -103.05 |
Net Income | -33.12 | -2.61 | -40.28 | -134.56 | -54.27 | -103.05 |
Net Income to Common | -33.12 | -2.61 | -40.28 | -134.56 | -54.27 | -103.05 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 770 | 770 | 770 | 770 | 770 | 770 |
Shares Outstanding (Diluted) | 770 | 770 | 770 | 770 | 770 | 770 |
Shares Change | - | - | - | - | - | -0.58% |
EPS (Basic) | -0.04 | -0.00 | -0.05 | -0.17 | -0.07 | -0.13 |
EPS (Diluted) | -0.04 | -0.00 | -0.05 | -0.17 | -0.07 | -0.13 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 14.96 | 2.87 | 14.3 | -28.97 | 41.72 |
Free Cash Flow Per Share | - | 0.02 | 0.00 | 0.02 | -0.04 | 0.05 |
Gross Margin | 25.54% | 36.78% | 30.82% | -32.24% | 20.05% | -6.83% |
Operating Margin | -32.25% | -12.68% | -18.01% | -76.94% | -27.02% | -44.56% |
Profit Margin | -38.98% | -2.62% | -35.47% | -91.96% | -38.21% | -60.59% |
Free Cash Flow Margin | - | 15.02% | 2.53% | 9.77% | -20.39% | 24.53% |
EBITDA | -27.26 | -12.45 | -20.12 | -112.2 | -38.2 | -75.48 |
EBITDA Margin | -32.08% | -12.50% | -17.72% | -76.68% | -26.89% | -44.38% |
D&A For EBITDA | 0.14 | 0.18 | 0.33 | 0.38 | 0.18 | 0.31 |
EBIT | -27.4 | -12.63 | -20.45 | -112.58 | -38.39 | -75.79 |
EBIT Margin | -32.25% | -12.68% | -18.01% | -76.94% | -27.02% | -44.56% |